Riskpilot← Back to searchSign inGet full accessIsostrof AB
ABActiveOrg 5566190889General medical practice activities · NACE 8621Est. 20010 employees
Revenue 2025
SEK 0
EBITDA margin
—
-65% vs 2024
Equity ratio
97.2%
Financial strength
Net profit 2025
SEK 12K
+16% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -19K | -65% |
| Net profit | SEK 12K | +16% |
| Total assets | SEK 397K | +3% |
| Equity | SEK 386K | +3% |
| Employees | 0 | — |
Legal name
Isostrof AB
Org number
5566190889
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 november 2001
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarverksamhet samt undervisning och föreläsningar inom detta område, vin- och spritimport, handel med värdepapper samt därmed förenlig verksamhet.
Address
Email
ragnarjohnsson@spray.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −6 | −8 | −2 | −12 | −19 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −6 | −8 | −2 | −12 | −19 |
| Net financials | 26 | 59 | −22 | 22 | 31 |
| Profit before tax | 20 | 51 | −24 | 10 | 12 |
| Tax | −0 | — | — | — | — |
| Net profit | 20 | 51 | −24 | 10 | 12 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 349 | 401 | 375 | 385 | 397 |
| Equity | 337 | 388 | 364 | 374 | 386 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 11 | 13 | 11 | 11 | 11 |
| Total debt | 11 | 13 | 11 | 11 | 11 |
EBITDA margin
-1927600.0%
This company
15.8%
Market median
-12200100% vs market
20212025
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
3.1%
This company
18.4%
Market median
-83% vs market
20212025
Net profit margin
1186600.0%
This company
8.1%
Market median
+14649283% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Isostrof AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Ragnar Johnsson | Board of Directors | 0 companies |
| Beatrix Hedvig Arvidsson | Deputy Board Member | 0 companies |